Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Spineology, Inc
The purpose of this study was to collect data that reports on the clinical outcomes of patients that were treated with the Spineology Rampart DUO device in a standard of care instrumented lateral lumbar interbody fusion procedure at one or two contiguous levels from L2-L5. Data was collected prospectively at specified time points per protocol and included both objective and subjective measures. The study concluded when the final patient achieved their 12-month evaluation.
Age
21–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
A clinical decision has been made to treat the patient with the Rampart Duo Interbody Spacer prior to enrollment into this research evaluation. This decision is independent (made outside) of the decision to take part in the research.
You may not be if
Previous interbody fusion or total disc replacement at the index level(s).
Enrolled in a concurrent clinical investigation that may confound the findings of the present investigation.
Clareo Health | Rampart Duo Clinical (RaDical) Post-Market Study
